MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an update. On December 10, 2025, MAIA Biotechnology announced a significant advancement in the ...

The final draft of the FY 2026 National Defense Authorization Act (NDAA) includes the proposed BIOSECURE Act (the Act), which would place ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint ...

Hong Kong and India lead Asia's fundraising surge, with record IPOs and robust market activity amid rising investor ...

The latest insider buying arrives as ateganosine continues to deliver encouraging results. These outcomes have strengthened internal and external confidence that MAIA’s novel telomere-targeting ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has issued an update. Shanghai Henlius Biotech, Inc. announced the approval of phase 2/3 ...

Depth Analysis of Bioseparation Systems Market, Highlighting Trends, Technologies, ESG Insights, and Growth Potential Through ...

Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in ...

The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will deliver the keynote address at the 2026 MDA ...

The National Biotechnology Research and Development Agency has convened a multi-stakeholder review and validation workshop to update and strengthen the National Biotechnology Policy and reposition ...

A long-sought crackdown on outbound American investment in China is on the verge of becoming law after House lawmakers ...

Phase 1/2 Trial Confirms Safety With Repeated Dosing Supporting Further Development in Early-stage Disease and Combination Treatment Settings ATLANTA, GA - December 8, 2025 (NEWMEDIAWIRE) - GeoVax ...